Multiple Sclerosis Analytical Report
More than 2.3 million people are living with MS worldwide. Although there is no cure, new research and innovative treatments are continuously emerging.
Regulations
Transforming Clinical Development
The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical, medical device and diagnostics manufactures to identify failures early, in order to minimize costs,...
Article on Viral Clearance for Biopharmaceuticals
Viral clearance studies are mandated prior to entering clinical trials and for commercial launch of biopharmaceuticals. These studies are a key component of risk mitigation to reduce the...
Customized Biosimilarity Analytical Testing from Catalent
Assessment of biosimilar molecules requires an orthogonal analytical approach. Any one particular analytical technique is not able to fully define the physical and biological characteristics of...